Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch

The targeted inactivation of oncogenes offers a rational therapeutic approach for the treatment of cancer. However, the therapeutic inactivation of a single oncogene has been associated with tumor recurrence. Therefore, it is necessary to develop strategies to override mechanisms of tumor escape fro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Giuriato, Sylvie, Ryeom, Sandra, Fan, Alice C., Bachireddy, Pavan, Lynch, Ryan C., Rioth, Matthew J., van Riggelen, Jan, Kopelman, Andrew M., Passegué, Emmanuelle, Tang, Flora, Folkman, Judah, Felsher, Dean W.
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2006
Teme:
Biological Sciences
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1637571/
https://ncbi.nlm.nih.gov/pubmed/17056717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0608017103
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items